Wave Life Sciences
90 hedge funds and large institutions have $149M invested in Wave Life Sciences in 2021 Q4 according to their latest regulatory filings, with 18 funds opening new positions, 40 increasing their positions, 17 reducing their positions, and 16 closing their positions.
135% more repeat investments, than reductions
Existing positions increased: 40 | Existing positions reduced: 17
98% more call options, than puts
Call options by funds: $236K | Put options by funds: $119K
13% more first-time investments, than exits
New positions opened: 18 | Existing positions closed: 16
6.67% more ownership
Funds ownership: 73.72% → 80.4% (+6.7%)
2% more funds holding
Funds holding: 88 → 90 (+2)
19% less capital invested
Capital invested by funds: $184M → $149M (-$35M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MC
Maverick Capital
Dallas,
Texas
|
+$9.97M |
| 2 |
BG
Bellevue Group
Kuesnacht,
Switzerland
|
+$8.3M |
| 3 |
LGM
Logos Global Management
San Francisco,
California
|
+$3.32M |
| 4 |
SG Americas Securities
New York
|
+$2.94M |
| 5 |
PIM
Platinum Investment Management
Sydney Australia 2000,
Australia
|
+$2.33M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DM
Deerfield Management
New York
|
-$11.1M |
| 2 |
6CM
683 Capital Management
New York
|
-$1.56M |
| 3 |
Bank of Montreal
Toronto,
Ontario, Canada
|
-$1.11M |
| 4 |
HP
Hound Partners
New York
|
-$886K |
| 5 |
NCM
Nantahala Capital Management
New Canaan,
Connecticut
|
-$361K |
WVE Hedge Fund Activity: Q4 2021 in Review
90 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in Wave Life Sciences (WVE) for Q4 2021, worth a combined $149M — down 19% from $184M a quarter earlier.
Buyers outnumbered sellers: 18 funds opened new WVE positions and 16 closed out — a net gain of 2 holders — while 40 added to existing stakes and 17 trimmed.
The largest buyer was Maverick Capital, adding an estimated $9.97M. The largest seller was Deerfield Management, cutting an estimated $11.1M.
- 90 institutional investors held Wave Life Sciences (WVE) as of Q4 2021, up from 88 in Q3 2021.
- Funds reported $149M of Wave Life Sciences stock for Q4 2021, down 19% quarter-over-quarter.
- 18 funds opened new Wave Life Sciences positions in Q4 2021 and 16 closed out, a net change of +2 holders.
- The largest Wave Life Sciences buyer in Q4 2021 was Maverick Capital, an estimated $9.97M added.
- The largest Wave Life Sciences seller in Q4 2021 was Deerfield Management, an estimated $11.1M sold.
Based on aggregated 13F filings for Q4 2021.